Skip to main content
Cellectis logo

Cellectis - Investor Relations & Filings

Listed IPO Feb 2007
Ticker · ALCLS ISIN · FR0010425595 LEI · 5493000KKX5VQ37Q2W83 PA Manufacturing
Open in API
Filings indexed 1,337 across all filing types
Latest filing 2026-07-02 Major Shareholding Noti…
Country FR France
Listing PA ALCLS · 12 venues

About Cellectis

https://cellectis.com/en

Cellectis is a clinical-stage biopharmaceutical company specializing in the development of immunotherapies to treat cancer. The company leverages its proprietary gene-editing platform, TALEN®, to engineer Chimeric Antigen Receptor (CAR) T-cells. Its primary focus is on creating allogeneic, or 'off-the-shelf', CAR T-cell product candidates. These therapies are derived from T-cells from healthy donors and are designed to be broadly available for a large number of patients, in contrast to autologous therapies custom-made for each individual. The TALEN® technology is used to address key challenges in allogeneic cell therapy, including preventing Graft-versus-Host Disease and mitigating rejection by the patient's immune system.

Recent filings

Filing Released Lang Actions
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
Major Shareholding Notification Classification Held out of the broad gpt-era re-classification: filing ingested <48h ago, so a realtime re-analysis could re-fire a filing.processed webhook. Prior label kept. 2026-07-04.
2026-07-02 French
Monthly information on share capital and company voting rights
Major Shareholding Notification Classification Held out of the broad gpt-era re-classification: filing ingested <48h ago, so a realtime re-analysis could re-fire a filing.processed webhook. Prior label kept. 2026-07-04.
2026-07-02 English
6-K/A
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an Amendment 6-K/A filing by a foreign private issuer, Cellectis S.A., related to corrected voting results from a Combined General Meeting held on June 25, 2026. It specifically addresses a correction of a clerical error in the voting results previously reported. The text references the voting results exhibit and clearly focuses on announcing and correcting the official voting results from the shareholder meeting. There is no substantive financial report, analysis, or detailed financial data present. The document is centered on the announcement of shareholder meeting voting results, which fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The character count is relatively short (~2688 characters), supporting it as an announcement rather than a full report. Therefore, the best classification is DVA with high confidence.
2026-06-26 English
Résultats de l’Assemblée Générale Mixte de Cellectis du 25 juin 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a press release announcing the results of an Annual General Meeting (Assemblée Générale Mixte). It explicitly states the voting outcomes (resolutions adopted/rejected) and provides a link to the detailed voting results. This fits the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2026-06-25 French
Cellectis Reports Results from Shareholders Meeting Held on June 25, 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a press release announcing the results of a shareholders' meeting held on June 25, 2026. It explicitly states that resolutions were adopted or rejected and directs readers to the company website for the detailed voting results. This fits the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2026-06-25 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filing, which is used by foreign private issuers to provide reports pursuant to SEC rules. It references a press release dated June 25, 2026, attached as Exhibit 99.1. The actual content of the report is a notification of an attachment (the press release), but the filing itself contains no detailed financials or substantive financial data. The length is 2707 characters, which is relatively short and consistent with an announcement rather than a full report. This aligns with the 'MENU VS MEAL' rule indicating that this is an announcement rather than the report itself. Therefore, the most appropriate classification is Regulatory Filings (RNS) as this report does not include a detailed financial report but rather an SEC Form 6-K with an attached press release.
2026-06-25 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.